Novartis Pharmaceuticals UK Ltd

Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
Telephone: +44 (0)1276 692 255
Fax: +44 (0)1276 698 449
Medical Information Direct Line: +44 (0)1276 698 370
Medical Information e-mail: medinfo.uk@novartis.com
Customer Care direct line: +44 (0)845 741 9442
Patient Information Leaflet last updated on the eMC: 18/04/2008
PIL MYFORTIC film coated gastro-resistant tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 18/04/2008 and displayed until Current
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 14/01/2008 and displayed until 18/04/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 14/09/2006 and displayed until 14/01/2008
Reasons for adding or updating:
  • Change to drug interactions
  • Change to side-effects
Updated on 02/09/2004 and displayed until 14/09/2006
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   mycophenolic acid as mycophenolate sodium


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk